[1]
2023. Rapid & Low-Cost DPYD Genotyping to Guide Fluoropyrimidine Treatment in Cancer Patients. Precision Medicine Communications. 3, 2 (Dec. 2023), 83–86. DOI:https://doi.org/10.55627/pmc.003.02.0485.